{"url_path":"/sec/drio/8-k/2026-07-22/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-22","source_url":"https://www.sec.gov/Archives/edgar/data/1533998/0001104659-26-085900-index.html","accession_number":"0001104659-26-085900","cik":"0001533998","ticker":"DRIO","issuer_name":"DarioHealth Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1533998/0001104659-26-085900-index.html","primary_entity_key":"0001533998","primary_entity_name":"DarioHealth Corp."},"word_count":312,"has_tables":true,"body_markdown":"false\n0001533998\n\n0001533998\n\n2026-07-22\n2026-07-22\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\n \n\n \n\n \n\n**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, D.C. 20549**\n\n \n\n**FORM 8-K**\n\n \n\n**CURRENT REPORT**\n\n**Pursuant to Section 13 or Section 15(d) of the\nSecurities Exchange Act of 1934**\n\n \n\nDate of Report (Date\nof Earliest Event Reported): July 22, 2026 (July 22, 2026)\n\n \n\n**DARIOHEALTH CORP.**\n\n(Exact name of registrant as specified in its charter)\n\n \n\nDelaware \n001-37704 \n45-2973162\n\n(State or other jurisdiction\n\nof incorporation) \n(Commission\n\nFile Number) \n(IRS Employer\n\nIdentification No.)\n\n \n\n**322\nW. 57th St****, #33B**\n\n**New York****, New\nYork****10019**\n\n(Address of Principal Executive Offices)\n\n \n\n**972- 4-770-4055**\n\n(Issuer’s telephone\nnumber)\n\n \n\n(Former name or former\naddress, if changed since last report)\n\n \n\nCheck the appropriate box below if the Form 8-K filing is intended\nto simultaneously satisfy the filing obligation to the registrant under any of the following provisions:\n\n \n\n¨\nWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)\n\n \n\n¨\nSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)\n\n \n\n¨\nPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\n \n\n¨\nPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))\n\n \n\nSecurities registered pursuant to Section 12(b)\nof the Act:\n\n \n\n**Title of each class**\n \n**Trading\n\nSymbol(s)**\n \n**Name of exchange on which \nregistered**\n\nCommon Stock, par value $0.0001 per share\n \nDRIO\n \nThe Nasdaq Capital Market LLC\n\n \n\nIndicate by check mark whether the registrant is an emerging growth\ncompany as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities\nExchange Act of 1934 (§240.12b-2 of this chapter).\n\n \n\nEmerging growth\ncompany ¨\n\n \n\nIf an emerging\ngrowth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any\nnew or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨"}